Cell Adhesion Molecule Like News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell adhesion molecule like. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Adhesion Molecule Like Today - Breaking & Trending Today

Targovax and Papyrus Therapeutics enter research collaboration to develop novel ONCOS viruses with receptor tyrosine kinase (RTK) inhibitor functionality


Targovax and Papyrus Therapeutics enter research collaboration to develop novel ONCOS viruses with receptor tyrosine kinase (RTK) inhibitor functionality
- The parties will explore the feasibility and effect of combining their respective oncolytic virus and receptor tyrosine kinase (RTK) inhibitor technologies
- Targovax retains the right to develop and commercialize novel drug candidates emerging from the pre-clinical collaboration
News provided by
Share this article
OSLO, Norway, Feb. 10, 2021 /PRNewswire/
Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, today announces that it has entered into a research collaboration agreement with Papyrus Therapeutics to assess the potential of combining their respective proprietary technology platforms to develop a first-in-class oncolytic virus concept with RTK inhibitor functionality.   ....

United States , Prnewswire Targovax , Victor Levitsky , Andreas Tinglum , Renate Birkeli , Paul Blake , Kim Sutton Golodetz , Corporate Communications Norway , Papyrus Therapeutics Inc , Papyrus Therapeutics , Opioid Binding , Cell Adhesion Molecule Like , Chief Executive Officer , Chief Scientific Officer , Sutton Golodetz , ஒன்றுபட்டது மாநிலங்களில் , வெற்றியாளர் லெவிட்ஸ்கி , பால் பிளேக் , பெருநிறுவன தகவல்தொடர்புகள் நோர்வே , பாப்பிரஸ் சிகிச்சை இன்க் , பாப்பிரஸ் சிகிச்சை , ஓபியாய்டு பிணைப்பு , தலைமை நிர்வாகி அதிகாரி , தலைமை அறிவியல் அதிகாரி ,